News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

8,238 stories indexed, page 26 of 138

🇪🇸Jun 2Regulatoryaemps.gob.es

Featured signal

La AEMPS informa del cese de comercialización y retirada del mercado del dispositivo antiatragantamientos DAEM

Publisher

AEMPS (Spain)

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

AEMPS (Spain)Original publisher link

Canonical metadata stays public, while full text remains on the original site.

🌍Jun 2Mediasaama.com

How the Medical Writing Demand Gap Is Becoming a Drug Development Bottleneck

SaamaOriginal source

🌍Jun 2Researchfiercepharma.com

ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection

Fierce Pharma ManufacturingOriginal source

🇬🇧Jun 2Researchnews.cancerresearchuk.org

Unlocking a new era for cancer prevention research

Cancer Research UKOriginal source

🇩🇪Jun 2pharma_equipmentsyntegon.com

Smooth capsule, tablet, and gummy supplement production

Syntegon (Bosch Packaging)Original source

🇬🇧Jun 2Researchphar.cam.ac.uk

Announcing the Cambridge Protein Screening Facility website!

Cambridge Pharma ResearchOriginal source

🌍Jun 2Industrysubtlemedical.com

Subtle Medical Secures $33 Million in Growth Capital Led by Morgan Stanley Expansion Capital and Appoints Industry Veteran Ohad Arazi as CEO

Subtle MedicalOriginal source

🌍Jun 2universitynews.mit.edu

Ultrasound-based pacemaker noninvasively steadies the heart

MIT Biology NewsOriginal source

🌍Jun 2Regulatorynafdac.gov.ng

NAFDAC Launches Improved Med Safety App to Strengthen Reporting of Substandard and Falsified Medical Products and Adverse Drug Reactions in Nigeria

NAFDAC NigeriaOriginal source

🇺🇸Jun 2Industrynews.abbvie.com

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

AbbVie NewsOriginal source

🌍Jun 2Industryhealth.ucdavis.edu

UC Davis Cancer Care Network expands rural access with new oncology team at Marshall

UC Davis HealthOriginal source

🌍Jun 2Industrymonashhealth.org

Hospital in the Home iron infusion referrals to change from 30 June

Monash HealthOriginal source

🌍Jun 2Industrymonashhealth.org

Update on recent changes to our pathology system

Monash HealthOriginal source

🌍Jun 2Industrymonashhealth.org

Prostate cancer education day: full-day session for GPs and health professionals

Monash HealthOriginal source

🌍Jun 2Industryaspenpharma.com

Stavros Nicolaou honoured with Lifetime Leadership Award

Aspen PharmacareOriginal source

🇺🇸Jun 2Mediabio-itworld.com

A ‘Credit-Score-Like’ Risk Assessment System for Investigative Drugs

Bio-IT WorldOriginal source

🇨🇭Jun 2Industryroche.com

FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting

Roche NewsroomOriginal source

🇦🇺Jun 2Researchnews.flinders.edu.au

MRFF drives better mental health at home for older Australians

Flinders University - Health & MedOriginal source

🇯🇵Jun 2Devicesolympus-global.com

(Progress of disclosure matters) Notice Regarding Completion of Acquisition of BioProtect Ltd.

Olympus MedicalOriginal source

🌍Jun 2Researchnews.uci.edu

Engineering students win NASA Blue Skies Award

University of California IrvineOriginal source

🌍Jun 2Researchnews.uci.edu

UC Irvine-led research team to develop evaluation protocols, tools for city chatbots

University of California IrvineOriginal source

🇪🇸Jun 2Industryrovi.es

Resultados financieros del primer semestre de 2026

Laboratorios RoviOriginal source

🇪🇸Jun 2Researchcnic.es

El encuentro SAFE HEARTS PLAN: Young Scientists Engaging with Europe’s Cardiovascular Health Plan acerca a jóvenes investigadores las políticas europeas de salud cardiovascular en Europa

CNIC Spain CardiovascularOriginal source

🇺🇸Jun 2CROadvarra.com

A Practical Checklist for Building Confidence in Site Selection

Advarra (IRB)Original source

🌍Jun 2Researchuab.edu

What to know about male infertility from a UAB urologist

University of Alabama at BirminghamOriginal source

🇦🇺Jun 2Researchnews.flinders.edu.au

Commonly prescribed medication for sleep problems raises alarm bells

Flinders University - Health & MedOriginal source

🇺🇸Jun 2Industryneogenomics.com

Biopharma partnerships

NeoGenomicsOriginal source

🇺🇸Jun 2CROadvarra.com

Sponsor’s Guide to IRB Approval (Part VI): After IRB Approval: Compliance, Multi-Site Oversight, and Turning Review into a Strategic Advantage

Advarra (IRB)Original source

🇨🇭Jun 2CROpsi-cro.com

PSI CRO Appoints Misoon Seo to Lead South Korea Operations

PSI CROOriginal source

🌍Jun 2Industryfiercepharma.com

Fueling Pharma's AI Revolution with the Right Content, Governance and Licensing Strategy

Fierce Pharma (Latest)Original source

🌍Jun 2Researchanswers.childrenshospital.org

Nanoparticle drug combo treats venous malformations

Boston Children's HospitalOriginal source

🇺🇸Jun 2Industryfatetherapeutics.com

Preliminary Phase 1 Results of a MICA/B-targeted CAR T cell Designed to Overcome Solid Tumor Escape Mechanisms and Avoid the Requirement for Conditioning Chemotherapy

Fate TherapeuticsOriginal source

🇺🇸Jun 2Industry4gclinical.com

No. Matter. What: Evidence That Reflects Every Patient

4G ClinicalOriginal source

🌍Jun 2Regulatorybioworld.com

Policy, aka politics, to have bigger role in US grants?

BioWorld Regulatory RSSOriginal source

🇩🇪Jun 1Researchfraunhofer.de

Innovation From Above: How Mesh Networks Help Control Drone Swarms

Fraunhofer Life SciencesOriginal source

🇩🇪Jun 1Researchfraunhofer.de

Improving the Availability of mRNA-Based Drugs

Fraunhofer Life SciencesOriginal source

🇩🇪Jun 1Researchfraunhofer.de

Efficiently Cooling Satellite Components in Space

Fraunhofer Life SciencesOriginal source

🇺🇸Jun 1CROmedpace.com

Expert Perspectives on the Transforming Diabetes Clinical Trial Landscape

MedpaceOriginal source

🌍Jun 1Industryaspenpharma.com

Aspen Oss earns EcoVadis Gold

Aspen PharmacareOriginal source

🇺🇸Jun 1Researchorbimed.com

Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline

OrbiMedOriginal source

🇪🇸Jun 1Regulatoryaemps.gob.es

ORAMORPH 2 MG/ML SOLUCION ORAL , 1 frasco de 100 ml (NR: 62039, CN: 821934)

AEMPS (Spain)Original source

🌍Jun 1universitynews.mit.edu

Enzymes that assemble into droplets can speed up cellular reactions

MIT Biology NewsOriginal source

🇪🇸Jun 1Regulatoryaemps.gob.es

Solución cardiopléjica, varias presentaciones

AEMPS (Spain)Original source

🇺🇸Jun 1Industryneogenomics.com

PanTracer™ Portfolio

NeoGenomicsOriginal source

🇬🇧Jun 1Researchukri.org

First projects funded by Local Innovation Partnership Fund

Medical Research Council (UKRI)Original source

🇪🇸Jun 1Regulatoryaemps.gob.es

La AEMPS informa del cambio en la denominación de Valium solución inyectable para evitar errores de medicación

AEMPS (Spain)Original source

🇩🇪Jun 1Researchklinikum.uni-heidelberg.de

Exzellente Doktorandenausbildung geht in die zweite Runde: Medizinische Fakultäten der Universität Heidelberg setzen erfolgreiches Graduiertenkolleg auf dem Gebiet der Immunologie fort

Universitätsklinikum HeidelbergOriginal source

🌍Jun 1Industryorthofix.com

From Nerve Pain to Full Recovery: Jason’s CervicalStim Device Experience

OrthofixOriginal source

🌍Jun 1Regulatoryargentina.gob.ar

Actualización de aranceles para trámites en ANMAT

ANMAT NoticiasOriginal source

🇺🇸Jun 1Industryinvestors.abeonatherapeutics.com

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona TherapeuticsOriginal source

🇺🇸Jun 1Industrymerck.com

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

Merck & Co. (MSD) NewsOriginal source

🇯🇵Jun 1Researchkyoto-u.ac.jp

Delegation from Newcastle University visits Kyoto University

Kyoto UniversityOriginal source

🇯🇵Jun 1Researchkyoto-u.ac.jp

Professor Emerita Caroline Sy Hau receives Fukuoka Prize 2026 Academic Prize

Kyoto UniversityOriginal source

🇺🇸Jun 1CROir.criver.com

Charles River Laboratories to Present at William Blair and Jefferies Conferences

Charles River LaboratoriesOriginal source

🇺🇸Jun 1Industryinvestors.amneal.com

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Amneal Pharmaceuticals RSSOriginal source

🇩🇪Jun 1Researchuni-heidelberg.de

Research Training Group in the Field of Immunology Continues Successful Work

Heidelberg UniversityOriginal source

🌍Jun 1Medianovartis.com

Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML

NovartisOriginal source

🇮🇹Jun 1Researchpoliclinico.mi.it

#CONVEGNO. [09.06] Innovazioni terapeutiche nel segmento anteriore: dall’occhio secco alle patologie corneali e congiuntivali complesse

Policlinico di MilanoOriginal source

🇺🇸Jun 1Industrybristolmyers2016ir.q4web.com

U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Bristol-Myers Squibb NewsOriginal source

🇺🇸Jun 1Industrybristolmyers2016ir.q4web.com

Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma

Bristol-Myers Squibb NewsOriginal source

Pharmaceutical industry news

Search-friendly hub pages

Regulatory Updates

Clinical Trial Watch

Drug Pipeline

Every signal, indexed and searchable

Latest indexed stories

La AEMPS informa del cese de comercialización y retirada del mercado del dispositivo antiatragantamientos DAEM

How the Medical Writing Demand Gap Is Becoming a Drug Development Bottleneck

ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection

Unlocking a new era for cancer prevention research

Smooth capsule, tablet, and gummy supplement production

Announcing the Cambridge Protein Screening Facility website!

Subtle Medical Secures $33 Million in Growth Capital Led by Morgan Stanley Expansion Capital and Appoints Industry Veteran Ohad Arazi as CEO

Ultrasound-based pacemaker noninvasively steadies the heart

NAFDAC Launches Improved Med Safety App to Strengthen Reporting of Substandard and Falsified Medical Products and Adverse Drug Reactions in Nigeria

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

UC Davis Cancer Care Network expands rural access with new oncology team at Marshall

Hospital in the Home iron infusion referrals to change from 30 June

Update on recent changes to our pathology system

Prostate cancer education day: full-day session for GPs and health professionals

Stavros Nicolaou honoured with Lifetime Leadership Award

A ‘Credit-Score-Like’ Risk Assessment System for Investigative Drugs

FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting

MRFF drives better mental health at home for older Australians

(Progress of disclosure matters) Notice Regarding Completion of Acquisition of BioProtect Ltd.

Engineering students win NASA Blue Skies Award

UC Irvine-led research team to develop evaluation protocols, tools for city chatbots

Resultados financieros del primer semestre de 2026

El encuentro SAFE HEARTS PLAN: Young Scientists Engaging with Europe’s Cardiovascular Health Plan acerca a jóvenes investigadores las políticas europeas de salud cardiovascular en Europa

A Practical Checklist for Building Confidence in Site Selection

What to know about male infertility from a UAB urologist

Commonly prescribed medication for sleep problems raises alarm bells

Biopharma partnerships

Sponsor’s Guide to IRB Approval (Part VI): After IRB Approval: Compliance, Multi-Site Oversight, and Turning Review into a Strategic Advantage

PSI CRO Appoints Misoon Seo to Lead South Korea Operations

Fueling Pharma's AI Revolution with the Right Content, Governance and Licensing Strategy

Nanoparticle drug combo treats venous malformations

Preliminary Phase 1 Results of a MICA/B-targeted CAR T cell Designed to Overcome Solid Tumor Escape Mechanisms and Avoid the Requirement for Conditioning Chemotherapy

No. Matter. What: Evidence That Reflects Every Patient

Policy, aka politics, to have bigger role in US grants?

Innovation From Above: How Mesh Networks Help Control Drone Swarms

Improving the Availability of mRNA-Based Drugs

Efficiently Cooling Satellite Components in Space

Expert Perspectives on the Transforming Diabetes Clinical Trial Landscape

Aspen Oss earns EcoVadis Gold

Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline

ORAMORPH 2 MG/ML SOLUCION ORAL , 1 frasco de 100 ml (NR: 62039, CN: 821934)

Enzymes that assemble into droplets can speed up cellular reactions

Solución cardiopléjica, varias presentaciones

PanTracer™ Portfolio

First projects funded by Local Innovation Partnership Fund

La AEMPS informa del cambio en la denominación de Valium solución inyectable para evitar errores de medicación

Exzellente Doktorandenausbildung geht in die zweite Runde: Medizinische Fakultäten der Universität Heidelberg setzen erfolgreiches Graduiertenkolleg auf dem Gebiet der Immunologie fort

From Nerve Pain to Full Recovery: Jason’s CervicalStim Device Experience

Actualización de aranceles para trámites en ANMAT

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA&reg; (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

Delegation from Newcastle University visits Kyoto University

Professor Emerita Caroline Sy Hau receives Fukuoka Prize 2026 Academic Prize

Charles River Laboratories to Present at William Blair and Jefferies Conferences

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Research Training Group in the Field of Immunology Continues Successful Work

Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML

#CONVEGNO. [09.06] Innovazioni terapeutiche nel segmento anteriore: dall’occhio secco alle patologie corneali e congiuntivali complesse

U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting